Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-05 for Common Warts
NCT02798419Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jan 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of DFD-05 in common warts (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Proportion of treatment responders at 12 weeks. Started Jan 2016; status: completed.
02
Drugs
DFD-05
03
Conditions
common warts
Beyond the preview
Go deeper on NCT02798419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798419.